肤色皮肤中皮肤病的遗传学、生物学和表型变异。第二部分:肤色皮肤中皮肤病的临床表现差异和差异
本文为继续医学教育(CME)文章第二部分,讨论特应性皮炎、银屑病、化脓性汗腺炎以及黑色素瘤、基底细胞癌和皮肤T细胞淋巴瘤在肤色皮肤(SOC)患者中的临床表现差异及相关健康差异。文章未报告具体研究数据或推荐意见。
要点
- 肤色皮肤(SOC)患者常见及少见皮肤病的临床表现和治疗知识仍存在缺口。
- 需提高对 disproportionately 影响SOC患者的差异的认识以解决皮肤科健康不公平。
- 本文重点讨论特应性皮炎、银屑病、化脓性汗腺炎及三种皮肤肿瘤的临床表型差异和健康差异。
核心结论
- 肤色皮肤(SOC)患者中常见和少见皮肤病的临床表现与治疗仍存在知识缺口,需提高对健康差异的认识以解决皮肤科健康不公平。
研究设计与样本
- 本文为继续医学教育(CME)文章的第二部分,讨论肤色皮肤中炎症性疾病和皮肤恶性肿瘤的临床表型差异及健康差异,未报告系统检索范围或研究样本。
主要发现
- 本文重点阐述特应性皮炎、银屑病、化脓性汗腺炎以及黑色素瘤、基底细胞癌和皮肤T细胞淋巴瘤在肤色皮肤患者中的临床表现差异。
- 文中还讨论了与上述每种疾病相关的健康差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Skin of color (SOC) patients are projected to comprise the majority of the population by 2044, yet knowledge gaps in the clinical presentation and treatment of both common and uncommon dermatologic conditions in skin of color persist. Improved awareness of disparities that disproportionately impact SOC patients is necessary to address health inequity in the field of dermatology. The first part of this CME discussed structural, genetic, and immunophenotypic differences in SOC in common inflammatory disorders as well as cutaneous malignancies. The second part of this CME highlights clinical differences in the phenotypic presentation of the inflammatory disorders of atopic dermatitis, psoriasis, and hidradenitis suppurativa as well as the cutaneous malignancies of melanoma, basal cell carcinoma, and cutaneous T-cell lymphoma. Health disparities associated with each of these conditions are also discussed.
引用
- McKenzie S, Brown-Korsah JB, Syder NC, et al. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color. J Am Acad Dermatol. 2022. PMID: 35817332. doi:10.1016/j.jaad.2022.03.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。